Abry Partners to sell Sentry Data System for USD400m
Abry Partners, a Boston-based private equity firm, is to sell Sentry Data Systems, a specialist in pharmacy procurement, compliance and utilisation management, to Craneware plc (AIM: CRW.L), a provider of Value Cycle solutions for the US healthcare market, for USD400 million.
Sentry Data Systems, Inc, headquartered in Deerfield Beach, Florida, is a leading provider of SaaS solutions which simplify the complexity of pharmacy procurement, utilisation and 340B regulatory compliance in order to maximise cost savings, improve patient outcomes and ensure precise regulatory compliance. Sentry also provides business intelligence and SaaS analytics solutions and consulting services. Visit sentryds.com.
Brent Stone, Partner at Abry Partners, says: “Since our acquisition in 2015 we have worked with CEO Travis Leonardi to grow the company and continue to innovate in the 340B industry, which today serves a customer base of more than 10,000 hospitals, pharmacies and clinics. We want to thank Travis and the entire Sentry team for their partnership and dedication and believe strongly that this is a compelling combination for all stakeholders.”
TJ Rose, Partner at Abry Partners, says: “We have been proud to support Travis and the Sentry team in continuing their history of innovation and leadership within the sector. We are excited to watch their continued success as they are further empowered by Craneware.”
Travis Leonardi, RPh, CEO at Sentry Data Systems, says: “It’s been a privilege to work with ABRY these past six years. Sentry looks forward to continuing to innovate and grow with its new partnership with Craneware.”
The transaction is subject to customary closing conditions and is expected to close over the next month. Piper Sandler served as financial advisor to Abry and DLA Piper provided legal counsel.